BioPharma
08 October, 2024 | Tuesday | News
SK bioscience Invests USD 3 Million in FinaBio to Enhance Next-Generation Conjugate Vaccine Development
SK bioscience invested USD 3 million in FinaBio, a U.S. company specializing in next-generation conjugate vaccine technology. With the agreement, SK bioscience expects to improve the immunogenicity and produ...
Lab
09 October, 2024 | Wednesday | News
Bio-Rad Launches Vericheck ddPCR™ Kit for Precise AAV Vector Quality Assessment
Bio-Rad Laboratories, a global leader in life science research and clinical diagnostics products, announced the launch of the Vericheck ddPCR™ Empty-Full Capsid Kit for the determination of capsid titer, ...
BioTech
07 October, 2024 | Monday | News
MicroRNA Breakthrough Wins Nobel Prize: Ambros and Ruvkun Transform Our Understanding of Gene Regulation
The Nobel Assembly at the Karolinska Institutet has awarded the prestigious 2024 Nobel Prize in Physiology or Medicine to Dr. Victor Ambros and Dr. Gary Ruvkun for their transformative discovery of microRNA and...
Contract Services
08 October, 2024 | Tuesday | News
Synexa Life Sciences Acquires Alderley Analytical Ltd, Strengthening Bioanalytical Capabilities and Expanding European Reach
Synexa Life Sciences, a specialist biomarker and bioanalysis service provider, announces the acquisition of Alderley Analytical Ltd, based near Manchester, UK. This transaction reflects an important...
Consumer Health
03 October, 2024 | Thursday | News
Hetero and Gilead Sciences Partner to Expand Global Access to Lenacapavir for HIV Treatment and Prevention
Non-exclusive voluntary license agreement enables the manufacture and distribution of lenacapavir for HIV prevention and treatment of heavily treatment-experienced patients with multi drug-resistant HIV Hetero...
White Paper
30 August, 2024 | Friday | Report
New Trials, New Pills—The Pharma Rollercoaster Continues!
Product Spot Light
09 October, 2024 | Wednesday | News
Bio-Rad Launches Vericheck ddPCR™ Kit for Precise AAV Vector Quality Assessment
Premium Article
20 September, 2024 | Friday | Opinion
The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
Bio Invest
08 October, 2024 | Tuesday | News
SK bioscience Invests USD 3 Million in FinaBio to Enhance Next-Generation Conjugate Vaccine Development
Biopharma APAC Infomercial
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
Editor Picks
